CIBC Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Sell
186,276
-2,966
-2% -$195K 0.03% 372
2026
Q1
$13.5M Sell
189,242
-996
-0.5% -$78.5K 0.03% 319
2025
Q4
$15.6M Buy
190,238
+49,815
+35% +$3.88M 0.04% 295
2025
Q3
$10.5M Buy
140,423
+73
+0.1% +$5.45K 0.03% 295
2025
Q2
$10.4M Sell
140,350
-6,754
-5% -$470K 0.03% 305
2025
Q1
$11.9M Buy
147,104
+886
+0.6% +$76.1K 0.04% 267
2024
Q4
$11.4M Buy
146,218
+5,009
+4% +$426K 0.04% 266
2024
Q3
$13.3M Buy
141,209
+10,974
+8% +$921K 0.04% 232
2024
Q2
$10.1M Buy
130,235
+1,747
+1% +$142K 0.04% 258
2024
Q1
$11.7M Buy
128,488
+10,326
+9% +$859K 0.04% 245
2023
Q4
$9.14M Buy
118,162
+640
+0.5% +$44.8K 0.03% 271
2023
Q3
$8M Buy
117,522
+15,232
+15% +$1.11M 0.03% 271
2023
Q2
$8.31M Buy
102,290
+50,881
+99% +$4.06M 0.03% 278
2023
Q1
$4.22M Buy
+51,409
New +$3.67M 0.02% 399

Other funds holding GEHC

CIBC Asset Management's GEHC Position: Q2 2026 in Review

CIBC Asset Management reduced its GE HealthCare (GEHC) stake by 1.6% in Q2 2026, selling an estimated $195K and leaving 186,276 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #372.

CIBC Asset Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $15.6M in Q4 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • CIBC Asset Management held 186,276 shares of GE HealthCare worth $11.9M as of Q2 2026.
  • CIBC Asset Management sold 2,966 GE HealthCare shares in Q2 2026, an estimated $195K.
  • GE HealthCare made up 0.03% of CIBC Asset Management's portfolio in Q2 2026, its #372 holding.
  • CIBC Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • CIBC Asset Management's GE HealthCare position peaked at $15.6M in Q4 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.